when fda approve compass pathways comp360 psilocybin

    Before Jan 1, 2027

    when fda approve compass pathways comp360 psilocybin. Best Yes near 41¢ across 1 platform. Live cross-platform prices. Not financial advice.

    Best Yes: 41¢ · Best No: 65¢ · 1 platform

    • Kalshi: Yes 41¢ / No 65¢
    TRADING OPEN

    Before Jan 1, 2027

    Volume

    $4.6K

    $16 24h

    Platforms

    1

    Cross-platform pricing

    Resolution

    Resolves Jun 30, 2027

    ~289 days left

    Category

    Culture

    41¢CHANCE OF YES39%61%
    Yes
    41¢
    Kalshi
    No
    65¢
    Kalshi

    Opens on best-price platform

    Compare & Trade

    1 platform
    kalshi
    Kalshi
    Best Yes
    Best No
    Yes
    41¢
    No
    65¢
    Vol
    $4.6K
    $16 24h
    Trade on Kalshi

    Price History

    Loading…

    About This Market

    If the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing before Jan 1, 2027, then the market resolves to Yes.

    Fee Impact at These Prices

    KalshiKalshiat 41¢: exit costs ~1.69¢/contract
    Full calculator

    Market Details

    ResolutionResolves Jun 30, 2027
    Time Left289 days
    Status● Active
    CategoryCulture

    Sign in to join the discussion

    Sign In